Advanced search
News (62)
Companies (2)
Jiangsu Riying Electronics Co Ltd is a China-based company mainly engaged in research and development, production and sales of auto parts. The company's products are divided into sensing products, transmission products, control products and others. The se ...
Rex International Holding Limited is a Singapore-based multinational oil exploration and production (E&P) company. The principal activity of the Company is investment holding. It has interests in exploration production licenses in Oman, Norway and Malaysi ...
Insiders
Jesper Riis holds the position of Group Chief Information Officer at DSV Panalpina A.
Mr. Jesper Mårtensson is a Chief Financial Officer at Fastighets AB Balder, an Independent Director at K-Fast Holding AB, a Chairman at Alnova Balkongsystem AB, a Chairman at Bobo Fastigheter AB, a Chairman at CIMalgo AB, a Chairman at Lönndungen AB and a Chairman at Tommy Byggare AB. He is on the Board of Directors at K-Fast Holding AB, Björkekärr Parkerings AB, Bostadsrättsförening önneredsbodarna, Erik Selin Bostadsgaranti AB, Erik Selin Fastigheter AB, MyBank ASA, önnered Fastighets AB, önneredsprojektet AB, Safehotels Alliance AB, Swedish Logistic Property AB, Swedish Logistic Property Förvaltning 1 AB and The Single Malt Fund AB (publ). He received his graduate degree from Auckland University and a graduate degree from the University of Gothenburg.
Jesper Kjaedegaard is a businessperson who founded Mercator International LLC and who has been at the helm of 5 different companies. Mr. Kjaedegaard is on the board of Red Sea Gateway Terminal Co. Ltd. and APM Terminals Bahrain BSC. In the past Mr. Kjaedegaard occupied the position of Chairman for APM Terminals Mumbai, Chairman of Maritime Uk Ltd., Chief Executive Officer for The Maersk Co. Ltd., Chief Executive Officer at A.P. Møller-Mærsk An and President at UK Chamber of Shipping. Mr. Kjaedegaard received an undergraduate degree from the University of Copenhagen.
Jesper Petersen has worked as a Senior Director-Group Compliance at DSV A since 2015.
Jesper Nielsen is a businessperson who has been at the helm of 11 different companies and presently is Chairman at Mobilepay Denmark AS, Chairman of Mobileday A, Chairman for Mobilepay AS and Chairman at e-nettet AS. He is also Deputy CEO & Head-Business Development at Nibdan Ltd. and Head-Personal Banking & Member-Management Board at Danske Bank A. In his past career he was Chairman at Realkredit Danmark A, Head of Banking at Danske Bank A, Chief Executive Officer & Head of Banking at Danske Bank A, Chief Executive Officer & Head of Banking at Danske Bank A, Chief Executive Officer & Head of Banking at Danske Bank An and Head-Marketing at BG Bank AS. Mr. Nielsen received a graduate degree from the University of Copenhagen.
Jens Jesper Ovesen is currently the Vice Chairman at Skandinaviska Enskilda Banken AB and the Executive Chairman at Nokia Solutions & Networks Australia Pty Ltd.
He previously held positions such as Chief Executive Officer at Baltica Bank A, Executive Chairman at Nokia Siemens Networks Oy, Nokia Siemens Networks US LLC, and Nokia Solutions & Networks Oy, Director at Hungarian Telephone & Cable Corp., Independent Director at Orkla ASA, Independent Director at H.
Lundbeck A, Director at DuPont Nutrition Biosciences ApS, Independent Director at FLSmidth & Co. A, Managing Director at Kirkbi Invest A, Independent Non-Executive Director at Sunrise Communications Group AG and Convatec Group Plc, Chief Financial Officer & Senior Executive VP at TDC Holding A, Chief Financial Officer at Novo Nordisk A, Lego Co. Ltd.
(United Kingdom), Danske Bank A, Baltica Holding A, LEGO A, and LEGO Holding A, and Member-Supervisory Board at Sunrise Communications AG.
He has a graduate degree from Copenhagen Business School and also attended Harvard Business School.
Bo Jesper Hansen founded Scandinavian Medical Research.
Dr. Hansen also currently works at Innoventa Medica ApS, as Chairman, Reapplix A, as Director, MipSalus ApS, as Director, CMC Sweden AB, as Director, Wellington Partners GmbH, as Venture Partner, and Amylon Therapeutics BV, as Member-Supervisory Board.
Dr. Hansen also formerly worked at Swedish Orphan International Holding AB, as President & Chief Executive Officer from 2009 to 2010, Swedish Orphan Biovitrum International AB, as President, Chief Executive Officer & Director from 1993 to 2010, 2941881 Canada, Inc., as Chairman, Karo Healthcare AB, as Chairman, Topotarget A, as Executive Chairman from 2013 to 2014, Biovitrum AB, as Chairman in 2010, Karolinska Development AB (Private Equity), as Chairman from 2011 to 2017, Ablynx NV, as Chairman in 2018, Orphazyme A, as Chairman from 2022 to 2023, Swedish Orphan Biovitrum AB, as Chairman from 2023 to 2024, Swedish Orphan Biovitrum AB, as Chairman from 2010 to 2016, Karolinska Development AB, as Chairman from 2013 to 2017, CMC Contrast AB, as Director, Hyperion Therapeutics, Inc., as Independent Non-Executive Director from 2011 to 2015, Rebus Holdings, Inc., as Independent Director from 2011 to 2017, Gambro AB, as Director from 2010 to 2012, Incentive AB, as Director, Valerio Therapeutics SA, as Director, Newron Pharmaceuticals SpA, as Independent Non-Executive Director from 2013 to 2018, ACE BioSciences ApS, as Director, Zymenex A, as Director from 2008 to 2013, Novagali Pharma SA, as Director-Supervisory Board from 2010 to 2011, Azanta A, as Non-Executive Director from 2015 to 2020, Ascelia Pharma AB, as Independent Director, Yamanouchi Nordic, as Medical Advisor, Synthélabo Scandinavia A, as Medical Advisor, and Pfizer ApS, as Medical Advisor.
Dr. Hansen received his doctorate degree in 1978 from the University of Copenhagen.
Glenn Riis worked as a Senior Managing Director & Head-Credit at RAIT Financial Trust.
Riis Gonzales is currently working as the Vice President-Development at New Mexico State University Foundation, Inc.
Bente Juel Riis is the founder of Nordic Bioscience A, which was founded in 1989.
She held the title of Director at the company.
She received an undergraduate degree from the University of Copenhagen in 1981.
Jakob Riis is currently the President & Chief Executive Officer at Falck A, the Chief Executive Officer & Director at Falck Danmark A, the Chief Executive Officer at Adelca ApS, and the Chairman at Falck Health Care Holding A.
He is also the Chairman of Falck Healthcare A, Copenhagen Institute of Interaction Design Aps, and a Non-Independent Director at H.
Lundbeck A.
Additionally, he serves as a Director at Dansk Erhverv and Response AS.
Previously, he held positions as a Director at Copenhagen Capacity, ALK-Abello A, and Novo Nordisk A, where he was the EVP & Head-North America Operations.
He also served as the President of Novo Nordisk, Inc. Dr. Riis obtained a graduate degree from the University of Copenhagen in 1993 and a doctorate degree from the same institution in 1998.
Carsten Riis has a current job as a Director at Foreningen Ap Pension FMBA.
Jesper - currently works as a Commercial Director at MeeW A.
Cleo Riis worked as a Secretary & Director-Investor Relations at XPonCard Group AB from 2009 to 2011.
Thomas Riis currently works at MIE5 Datterholding 8 ApS, as Chairman & Co-Chief Executive Officer from 2019, MANAGEMENT EQUITY VIETNAM I ApS, as Co-Chief Executive Officer, MAJ Invest Equity A, as Director from 2016, BLIP Systems A, as Director, and Mie4 Holding 2 ApS, as Director.
Mr. Riis also formerly worked at Lån & Spar Bank A, as Principal in 1998, North Sea Capital A, as Principal, PricewaterhouseCoopers Corporate Financ SAS, as Principal in 2001, and 3i Nordic Plc (United Kingdom), as Principal.
Mr. Riis received his graduate degree from the University of Copenhagen.
Malin Riis currently works as a General Counsel at VINNOVA AB.
Anders Riis currently works at Vestas Wind Systems A, as Vice President-Communications from 2021.
Kenneth M.
Riis is currently the President of Newcastle Investment Holdings Corp.
He was previously the President, Chief Executive Officer & Director of Rithm Capital Corp.
in 2013 and a Director at Drive Shack, Inc. from 2016 to 2017.
John Riis Mortensen currently works at Anapa Biotech A, as Chairman, Vivostat A, as Director from 2008, Vecata Invest A, as Investment Director from 2004, and Ranger Biotechnologies A, as Director.
Mr. Riis Mortensen also formerly worked at Zoetis Denmark ApS, as Director, LiPlasome Pharma A, as Director, CellCure A, as Director, Fluxome Sciences A, as Director, Bagger-Sørensen & Co. A, as Principal, and Cadbury Schweppes, as Principal.
Mr. Riis Mortensen received his graduate degree from the University of Aarhus.
Mr. Kristoffer Riis Iden is a Research Analyst at Arctic Securities ASA.
He held an internship position at Arctic Securities during his studies (2009) before being permanently employed.
Mr. Riis holds an MSc from the Norwegian School of Economics and Business Administration (NHH).
Nikolaj Aagaard Riis worked as a Director at Alectia A.
Jesper Wilgodt worked as Head-Investor Relations at Telia Co. AB.
Prior to that, he worked as a Research Analyst at ABG Sundal Collier AB and as an Analyst at ABG Sundal Collier ASA. Mr. Wilgodt completed his undergraduate degree at the University of Uppsala.
Jesper Andreasen is currently the Chief Executive Officer at Rødovre Centrum A, Chief Executive Officer at JA Holding 4 ApS, Chairman & Chief Executive Officer at Ja Holding 8 ApS, Chairman at GW Energi A, Director at CPHI-Holding A, Director at SSCP Projekt BH ApS, and Director at Core Bolig IV Investorkommanditaktieselskab Nr 6.
He was formerly the Chairman at Forstædernes Bank A.
Jesper Ygberg currently works at Netsurvey Sweden AB, as Sales Director & Customer Loyalty Services.
Jesper Kirkeby Hansen is the founder and CEO of TEFCOLD A since 1987.
He is currently a Director at PcP.
Danmark.
A.
Mr. Hansen's former positions include being the CEO of Skamol A from 2007 to 2016 and Vice President-Sales & Marketing at Cheminova A.
Jesper Berthold worked as a Procurement Director at Kemetyl AB from 2009 to 2010.
No results for this search
- Stock Market
- Advanced search
- Jesper Riis